Pharmacologic management of renovascular hypertension.
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000150:complications / Q000188:drug therapy; D001795:Blood Pressure Determination; D004232:Diuretics / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006965:Hyperplasia; D006977:Hypertension, Renal / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D008875:Middle Aged; D011300:Preoperative Care; D011859:Radiography; D012077:Renal Artery / Q000000981:diagnostic imaging; D012078:Renal Artery Obstruction / Q000150:complications; D012082:Renal Veins; D012083:Renin / Q000097:blood; D012110:Reserpine / Q000627:therapeutic use
D000959:Antihypertensive Agents; D004232:Diuretics; D006830:Hydralazine; D008750:Methyldopa; D012110:Reserpine; D012083:Renin; D006145:Guanethidine